BOA Technology v. MacNeill: Closure in Lace Closure Patent Dispute

Introduction

A nearly two-year patent infringement battle over innovative footwear closure technology reached its conclusion in July 2025 when BOA Technology, Inc. and MacNeill Engineering Company, along with co-defendants MacNeill Pride Group Corp. and Pride Manufacturing Company, LLC, jointly stipulated to dismiss all claims with prejudice. Filed in California’s Southern District Court on August 4, 2023, Case No. 3:23-cv-01431 centered on four BOA patents covering dial-based lace closure systems — technology that has redefined precision fit in athletic and performance footwear.

The case carried significant commercial weight, targeting five high-profile shoe models from PUMA and Skechers distributed through the MacNeill enterprise. For patent attorneys tracking footwear IP litigation, IP professionals monitoring wearable technology patent portfolios, and R&D teams navigating freedom-to-operate risk in the athletic footwear space, this case offers instructive lessons about assertion strategy, multi-defendant litigation, and the strategic calculus of dismissal-with-prejudice outcomes.

Case Overview

The Parties

The Patents at Issue

BOA asserted four issued U.S. patents:

• • US11633020B2 (App. No. US17/450263)
• • US9770070B2 (App. No. US14/297047)
• • US10362836B2 (App. No. US15/687299)
• • US10772388B2 (App. No. US16/103761)

These patents collectively cover dial-actuated closure mechanisms that enable micro-adjustable, reel-based lacing systems — a technological differentiator in performance footwear that allows precise tension control without traditional laces.

The Accused Products

BOA alleged infringement by five specific footwear products: Puma ALPHACAT NITRO Disc Spikeless Golf Shoes, Skechers GO GOLF Torque – Twist, Skechers Slip-ins: GO GOLF Elite 5, Skechers Twist-Fit: GO RUN Pulse – Twisted, and Skechers Twist-Fit: Vector-Matrix. The commercial significance is notable — these are active retail products from two globally recognized athletic footwear brands, suggesting downstream licensing exposure well beyond the named defendants.

Legal Representation

Plaintiff BOA was represented by attorneys Adrienne E. Dominguez, April Elizabeth Isaacson, Edward John Mayle, Elissa M. McClure, Kevin Michael Bell, Kristopher L. Reed, and Zoe Phelps Stendara, drawing from Holland & Knight LLP, Kilpatrick Townsend & Stockton LLP, and Latham & Watkins LLP — a formidable multi-firm coalition signaling aggressive enforcement intent.

Defendants were represented by Christopher Scott Marchese, James H.S. Young, Seth M. Sproul, and Todd J. Tiberi of Fish & Richardson PC and Tiberi Law Office, PC — well-recognized IP defense specialists.

📎 Search case docket records on PACER | Review asserted patents on USPTO Patent Full-Text Database

Litigation Timeline & Legal Analysis

Litigation Timeline & Procedural History

BOA filed suit in the Southern District of California — a venue with established IP litigation infrastructure and proximity to major footwear and consumer goods companies operating along the West Coast. The 720-day duration aligns with typical district court patent litigation timelines that include pleading phases, discovery, and claim construction proceedings before resolution, though the joint dismissal suggests the parties reached resolution before trial.

The case proceeded at the first-instance (district court) level with no appellate record generated, meaning no published claim construction order or merits ruling exists in the public record from this matter alone.

Outcome

On July 24, 2025, the court entered an order dismissing the action with prejudice pursuant to a joint motion and stipulation filed by all parties under Federal Rule of Civil Procedure 41(a)(1)(A)(ii). Each party was ordered to bear its own fees, costs, and expenses. No damages amount was disclosed, and no injunctive relief was referenced in the dismissal order.

Verdict Cause Analysis

The dismissal-with-prejudice mechanism under Rule 41(a)(1)(A)(ii) requires consent of all parties, confirming this was a negotiated resolution rather than a court-imposed outcome. Critically, dismissal with prejudice means BOA cannot re-file the same claims against these defendants on these patents for the same accused products — a meaningful concession that any settlement likely included compensatory terms not reflected in the public record.

The “each party bears its own fees” provision is a standard settlement-neutral clause that avoids triggering fee-shifting analysis under 35 U.S.C. § 285 (exceptional case doctrine), suggesting neither party sought to litigate an attorneys’ fees award — consistent with a confidential licensing or cross-licensing arrangement.

Legal Significance

Because no claim construction order or summary judgment ruling was issued (or at minimum published), this case does not generate direct precedential value on the scope of BOA’s closure system patent claims. However, its significance lies in what it signals: BOA’s willingness to enforce its portfolio against downstream distributors and component suppliers — not just end-brand manufacturers — reflects a sophisticated multi-defendant assertion strategy.

The involvement of both PUMA and Skechers products in the accused product list, yet the absence of those brands as direct defendants, raises important questions about supply chain indemnification obligations and whether MacNeill or Pride entities carried contractual responsibility for patent defense on behalf of their brand customers.

Strategic Takeaways

For Patent Holders: Targeting component suppliers and distributors (rather than retail brands) can create settlement leverage while avoiding the PR risk of suing well-known consumer brands directly. BOA’s multi-firm plaintiff team signals resource-intensive enforcement that can accelerate resolution timelines.

For Accused Infringers: Fish & Richardson’s involvement reflects the value of specialist IP defense counsel when facing a portfolio assertion across multiple patent families. Securing indemnification clauses in manufacturing and distribution agreements is critical when closure or mechanical component technology is central to the product.

For R&D Teams: Design-around freedom-to-operate (FTO) analysis must cover continuation patents (note the four distinct patent families spanning application numbers from US14/297047 through US17/450263), as BOA’s portfolio demonstrates continuation strategy that broadens claim coverage over time.

Industry & Competitive Implications

The footwear closure technology sector has seen intensifying IP competition as brands differentiate on fit precision and ease-of-use features. BOA’s dial-lace system is effectively the category-defining technology, and its licensing model depends on robust enforcement to sustain royalty value.

This case reflects a broader patent assertion trend in wearable and athletic performance technology: as closure systems, smart insoles, and adaptive fit mechanisms become commercially mainstream, patent portfolios in this space attract increasing litigation attention. Companies like Skechers and PUMA, whose products were implicated here, operate large-scale footwear lines where even a single infringing closure mechanism can expose entire product families.

The dismissed-with-prejudice outcome without public financial terms is consistent with confidential licensing resolutions increasingly common in footwear IP — where parties prefer commercial certainty over litigation risk, particularly when multi-patent portfolios and multiple product SKUs are at stake. For IP professionals tracking licensing market rates in closure technology, this case likely reflects an ongoing royalty or lump-sum arrangement, though specifics remain undisclosed.